{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T13:36:07Z","timestamp":1648992967596},"reference-count":11,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1097\/cmr.0000000000000086","type":"journal-article","created":{"date-parts":[[2014,6,10]],"date-time":"2014-06-10T12:39:08Z","timestamp":1402403948000},"page":"315-321","source":"Crossref","is-referenced-by-count":0,"title":["Comparative analysis of pathology and boronophenylalanine uptake in experimental orthotopic and heterotopic amelanotic melanoma"],"prefix":"10.1097","volume":"24","author":[{"given":"Ting","family":"Sun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanyan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tingfeng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xueshun","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guilin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongxin","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youxin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziwei","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-4-20210129","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1067\/mjd.2000.103981","article-title":"Amelanotic melanoma: the great masquerader.","volume":"42","author":"Koch","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"R2-4-20210129","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3171\/jns.1998.88.1.0011","article-title":"Demographics, prognosis, and therapy in 702 patients with brain metastases from malignant melanoma.","volume":"88","author":"Sampson","year":"1998","journal-title":"J Neurosurg"},{"key":"R4-4-20210129","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.mayocp.2012.07.006","article-title":"Melanoma brain metastases and vemurafenib: need for further investigation.","volume":"87","author":"Rochet","year":"2012","journal-title":"Mayo Clin Proc"},{"key":"R5-4-20210129","doi-asserted-by":"crossref","first-page":"3987","DOI":"10.1158\/1078-0432.CCR-05-0035","article-title":"Boron neutron capture therapy of cancer: current status and future prospects.","volume":"11","author":"Barth","year":"2005","journal-title":"Clin Cancer Res"},{"key":"R14-4-20210129","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1040-8428(02)00077-X","article-title":"Malignant melanoma.","volume":"47","author":"De Braud","year":"2003","journal-title":"Crit Rev Oncol Hematol"},{"key":"R15-4-20210129","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0014-5793(00)01795-6","article-title":"Activation of melanogenesis by vacuolar type H()-ATPase inhibitors in amelanotic, tyrosinase positive human and mouse melanoma cells.","volume":"478","author":"Ancans","year":"2000","journal-title":"FEBS Lett"},{"key":"R17-4-20210129","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1007\/s11864-013-0228-6","article-title":"Metastatic melanoma to the brain: surgery and radiation is still the standard of care.","volume":"14","author":"Nicholas","year":"2013","journal-title":"Curr Treat Options Oncol"},{"key":"R19-4-20210129","first-page":"6377","article-title":"Selective targeting of boronophenylalanine to melanoma in BALBc mice for neutron capture therapy.","volume":"47","author":"Coderre","year":"1987","journal-title":"Cancer Res"},{"key":"R24-4-20210129","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1158\/0008-5472.CAN-08-2345","article-title":"L-amino acid transporter-1 and boronophenylalanine-based boron neutron capture therapy of human brain tumors.","volume":"69","author":"Detta","year":"2009","journal-title":"Cancer Res"},{"key":"R25-4-20210129","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/00008390-200006000-00013","article-title":"Selective uptake of para-boronophenylalanine increases in amelanotic melanoma cells transfected by the tyrosinase gene.","volume":"10","author":"Hiratsuka","year":"2000","journal-title":"Melanoma Res"},{"key":"R27-4-20210129","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1034\/j.1600-0749.2002.00059.x","article-title":"Effect of boron neutron capture therapy for melanotic and amelanotic melanoma transplanted into mouse brain.","volume":"15","author":"Iwakura","year":"2002","journal-title":"Pigment Cell Res"}],"container-title":["Melanoma Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CMR.0000000000000086","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T20:17:05Z","timestamp":1621887425000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00008390-201408000-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":11,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/cmr.0000000000000086","relation":{},"ISSN":["0960-8931"],"issn-type":[{"value":"0960-8931","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]}}}